Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
Clinical trial NCT06967480 · RECRUITING
Trial details
- NCT number
- NCT06967480
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-31
- Primary completion
- 2027-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.